NCT04085640View on ClinicalTrials.gov

Obturator Nerve Block in Total Hip Arthrosplasty

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

September 22, 2020

Study Completion Date

September 22, 2020

Conditions
Primary Total Hip Arthroplasty
Interventions
OTHER

Obturator nerve block with ropivacaine 0.2%.

20 milliliters of ropivacaine 2 mg/mL will be injected in the interfacial plane between the pectineus and external obturator muscles.

OTHER

Obturator nerve block with isotonic saline

20 milliliters of isotonic saline will be injected in the interfacial plane between the pectineus and external obturator muscles.

Trial Locations (1)

31036

Clinique Medipole Garonne, Toulouse

All Listed Sponsors
lead

Clinique Medipole Garonne

OTHER

NCT04085640 - Obturator Nerve Block in Total Hip Arthrosplasty | Biotech Hunter | Biotech Hunter